FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Wolfgang Meyer-Sabellek

Research Profile

Disorders

Concepts & Ideas

Procedures

Esophagoscopy

Geographic Areas

Germany

Chemicals & Drugs

Devices

Metered Dose Inhalers

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
Henrik Watz; Christiane Woischwill; Kai Michael Beeh; Daniel Bock; AM Kirsten; Helgo Magnussen; Michael Meyer; Wolfgang Meyer-Sabellek; Frauke Pedersen; Katrin Schierhorn; Karin Vollhardt; Jutta Beier
Inhaled pan-selectin antagonist Bimosiamose attenuates airway inflammation in COPD.
AM Kirsten; Gunther Kretschmar; Wolfgang Meyer-Sabellek; Frauke Pedersen; Henrik Watz; Daniel Bock; Helgo Magnussen
Efficacy of the pan-selectin antagonist Bimosiamose on ozone-induced airway inflammation in healthy subjects--a double blind, randomized, placebo-controlled, cross-over clinical trial.
Heike Englert; Jacqueline Müller-Nordhorn; Sebastian Seewald; Frank Sonntag; Heinz Völler; Wolfgang Meyer-Sabellek; Karl Wegscheider; Eberhard Windler; Hugo Katus; Stefan N Willich
Is patient self-report an adequate tool for monitoring cardiovascular conditions in patients with hypercholesterolemia?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Wolfgang Meyer-Sabellek (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Henrik Watz; Christiane Woischwill; Kai Michael Beeh; Daniel Bock; AM Kirsten; Helgo Magnussen; Michael Meyer; Wolfgang Meyer-Sabellek; Frauke Pedersen; Katrin Schierhorn; Karin Vollhardt; Jutta Beier
Inhaled pan-selectin antagonist Bimosiamose attenuates airway inflammation in COPD.
Pulmonary pharmacology & therapeutics 2013;26(2):265-70.
2011: AM Kirsten; Gunther Kretschmar; Wolfgang Meyer-Sabellek; Frauke Pedersen; Henrik Watz; Daniel Bock; Helgo Magnussen
Efficacy of the pan-selectin antagonist Bimosiamose on ozone-induced airway inflammation in healthy subjects--a double blind, randomized, placebo-controlled, cross-over clinical trial.
Pulmonary pharmacology & therapeutics 2011;24(5):555-8.
2010: Heike Englert; Jacqueline Müller-Nordhorn; Sebastian Seewald; Frank Sonntag; Heinz Völler; Wolfgang Meyer-Sabellek; Karl Wegscheider; Eberhard Windler; Hugo Katus; Stefan N Willich
Is patient self-report an adequate tool for monitoring cardiovascular conditions in patients with hypercholesterolemia?
Journal of public health (Oxford, England) 2010;32(3):387-94.
2009: Stefan N Willich; Heike Englert; Frank Sonntag; Heinz Völler; Wolfgang Meyer-Sabellek; Karl Wegscheider; Eberhard Windler; Hugo Katus; Jacqueline Müller-Nordhorn
Impact of a compliance program on cholesterol control: results of the randomized ORBITAL study in 8108 patients treated with rosuvastatin.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2009;16(2):180-7.
2008: Jacqueline Müller-Nordhorn; Heike Englert; Karl Wegscheider; Hendrike Berger; Frank Sonntag; Heinz Völler; Wolfgang Meyer-Sabellek; Thomas Reinhold; Eberhard Windler; Hugo A Katus; Stefan N Willich
Productivity loss as a major component of disease-related costs in patients with hypercholesterolemia in Germany.
Clinical research in cardiology : official journal of the German Cardiac Society 2008;97(3):152-9.
2008: Marc Nocon; Joachim Labenz; Daniel Jaspersen; Andreas Leodolter; Wolfgang Meyer-Sabellek; Manfred Stolte; Michael Vieth; Tore Lind; Peter Malfertheiner; Stefan N Willich
Nighttime heartburn in patients with gastroesophageal reflux disease under routine care.
Digestion 2008;77(2):69-72.
2007: Marc Nocon; Joachim Labenz; Daniel Jaspersen; Wolfgang Meyer-Sabellek; Manfred Stolte; Tore Lind; Peter Malfertheiner; Stefan N Willich
Association of body mass index with heartburn, regurgitation and esophagitis: results of the Progression of Gastroesophageal Reflux Disease study.
Journal of gastroenterology and hepatology 2007;22(11):1728-31.
2007: Marc Nocon; Joachim Labenz; Daniel Jaspersen; Wolfgang Meyer-Sabellek; Manfred Stolte; Tore Lind; Peter Malfertheiner; Stefan N Willich
Long-term treatment of patients with gastro-oesophageal reflux disease in routine care - results from the ProGERD study.
Alimentary pharmacology & therapeutics 2007;25(6):715-22.
2006: Wolfgang Meyer-Sabellek; Helmut Brasch
Atherosclerosis, inflammation, leukocyte function and the effect of statins.
Journal of hypertension 2006;24(12):2349-51.
2006: Joachim Labenz; Marc Nocon; Tore Lind; Andreas Leodolter; Daniel Jaspersen; Wolfgang Meyer-Sabellek; Manfred Stolte; Michael Vieth; Stefan N Willich; Peter Malfertheiner
Prospective follow-up data from the ProGERD study suggest that GERD is not a categorial disease.
The American journal of gastroenterology 2006;101(11):2457-62.
2006: Daniel Jaspersen; Joachim Labenz; Stefan N Willich; Michael Kulig; Marc Nocon; Andreas Leodolter; Tore Lind; Wolfgang Meyer-Sabellek; Michael Vieth; M Stolte; Peter Malfertheiner
Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2006;38(4):233-8.
2006: Stefan N Willich; Marc Nocon; Michael Kulig; Daniel Jaspersen; Joachim Labenz; Wolfgang Meyer-Sabellek; Manfred Stolte; Tore Lind; Peter Malfertheiner
Cost-of-disease analysis in patients with gastro-oesophageal reflux disease and Barrett's mucosa.
Alimentary pharmacology & therapeutics 2006;23(3):371-6.
2006: Michael Vieth; Michael Kulig; Andreas Leodolter; Emma Nauclér; Daniel Jaspersen; Joachim Labenz; Wolfgang Meyer-Sabellek; Tore Lind; Stefan N Willich; Peter Malfertheiner; Manfred Stolte
Histological effects of esomeprazole therapy on the squamous epithelium of the distal oesophagus.
Alimentary pharmacology & therapeutics 2006;23(2):313-9.
2005: Peter Malfertheiner; Tore Lind; Stefan N Willich; Michael Vieth; Daniel Jaspersen; Joachim Labenz; Wolfgang Meyer-Sabellek; Ola Junghard; Manfred Stolte
Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD study.
Gut 2005;54(6):746-51.
2005: Bernd Brüggenjürgen; Dagmar Selim; Peter Kardos; Kai Richter; Claus Vogelmeier; Stephanie Roll; Wolfgang Meyer-Sabellek; Roland Buhl; Stefan N Willich
Economic assessment of adjustable maintenance treatment with budesonide/formoterol in a single inhaler versus fixed treatment in asthma.
PharmacoEconomics 2005;23(7):723-31.
2004: Stefan N Willich; Jacqueline Müller-Nordhorn; Frank Sonntag; Heinz Völler; Wolfgang Meyer-Sabellek; Karl Wegscheider; Eberhard Windler; Hugo Katus
Economic evaluation of a compliance-enhancing intervention in patients with hypercholesterolemia: design and baseline results of the Open Label Primary Care Study: Rosuvastatin Based Compliance Initiatives To Achievements of LDL Goals (ORBITAL) study.
American heart journal 2004;148(6):1060-7.
2004: Joachim Labenz; Daniel Jaspersen; Michael Kulig; Andreas Leodolter; Tore Lind; Wolfgang Meyer-Sabellek; Manfred Stolte; Michael Vieth; Stefan N Willich; Peter Malfertheiner
Risk factors for erosive esophagitis: a multivariate analysis based on the ProGERD study initiative.
The American journal of gastroenterology 2004;99(9):1652-6.
2004: Roland Buhl; Peter Kardos; K Richter; Wolfgang Meyer-Sabellek; Bernd Brüggenjürgen; Stefan N Willich; Claus Vogelmeier
The effect of adjustable dosing with budesonide/formoterol on health-related quality of life and asthma control compared with fixed dosing.
Current medical research and opinion 2004;20(8):1209-20.
2004: Michael Kulig; Marc Nocon; M Vieth; A Leodolter; Daniel Jaspersen; J Labenz; Wolfgang Meyer-Sabellek; M Stolte; T Lind; P Malfertheiner; Stefan N Willich
Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study.
Journal of clinical epidemiology 2004;57(6):580-9.
2004: Michael Vieth; Ulrich Peitz; Joachim Labenz; Michael Kulig; Emma Nauclér; Daniel Jaspersen; Wolfgang Meyer-Sabellek; Stefan N Willich; Tore Lind; Peter Malfertheiner; Manfred Stolte
What parameters are relevant for the histological diagnosis of gastroesophageal reflux disease without Barrett's mucosa?
Digestive diseases (Basel, Switzerland) 2004;22(2):196-201.
2003: Michael Kulig; Andreas Leodolter; Michael Vieth; E Schulte; Daniel Jaspersen; Joachim Labenz; Tore Lind; Wolfgang Meyer-Sabellek; Peter Malfertheiner; Manfred Stolte; Stefan N Willich
Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative.
Alimentary pharmacology & therapeutics 2003;18(8):767-76.
2003: Daniel Jaspersen; Michael Kulig; Joachim Labenz; Andreas Leodolter; Tore Lind; Wolfgang Meyer-Sabellek; Michael Vieth; Stefan N Willich; D Lindner; M Stolte; P Malfertheiner
Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study.
Alimentary pharmacology & therapeutics 2003;17(12):1515-20.
2001: Andreas Leodolter; Michael Kulig; H Brasch; Wolfgang Meyer-Sabellek; Stefan N Willich; Peter Malfertheiner
A meta-analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori-associated gastric or duodenal ulcer.
Alimentary pharmacology & therapeutics 2001;15(12):1949-58.
2001: Peter Kardos; Bernd Brüggenjürgen; A Martin; Wolfgang Meyer-Sabellek; K Richter; Claus Vogelmeier; S N Willlich; Roland Buhl
[Treatment of bronchial asthma using a new adjustable combination treatment plan: Asthma Control Plan (ATACO)].
Pneumologie (Stuttgart, Germany) 2001;55(5):253-7.